                         SEQUENCE LISTING

<110>  THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF
        ARIZONA
       UNIVERSITY OF HAWAII
 
<120>  APPLICATION OF NEUROPROTECTIVE BETA AMYLOID CORE PEPTIDES AND 
       PEPTIDOMIMETIC DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE

<130>  UNIA 16.46 PCT

<150>  62/377,556
<151>  2016-08-20

<160>  63    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  beta-amyloid core

<400>  1

Tyr Glu Val His His Gln 
1               5       


<210>  2
<211>  15
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  N-terminal beta-amyloid  fragment

<400>  2

Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln 
1               5                   10                  15  


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Asp, a conservative substitution thereof, or optionally present

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Ala, a conservative substitution thereof, or optionally present

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Glu, a conservative substitution thereof, or optionally present

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Phe, a conservative substitution thereof, or optionally present

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Arg, a conservative substitution thereof, or optionally present

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, a conservative substitution thereof, or optionally present

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Asp, a conservative substitution thereof, or optionally present

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Ser, a conservative substitution thereof, or optionally present

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Gly, a conservative substitution thereof, or optionally present

<220>
<221>  MISC_FEATURE
<222>  (10)..(15)
<223>  at least 50% identical to at least a YEVHHQ fragment  of SEQ ID 
       NO.

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Tyr or a conservative substitution thereof

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Glu or a conservative substitution thereof

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val or a conservative substitution thereof

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Gln, His, a conservative substitution thereof, or optionally 
       present

<400>  3

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa His His Xaa 
1               5                   10                  15  


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  4

Xaa Glu Val His His Gln 
1               5       


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  5

Tyr Xaa Val His His Gln 
1               5       


<210>  6
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  6

Tyr Glu Xaa His His Gln 
1               5       


<210>  7
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  7

Tyr Glu Val His His Xaa 
1               5       


<210>  8
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  8

Xaa Xaa Val His His Gln 
1               5       


<210>  9
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  9

Xaa Glu Xaa His His Gln 
1               5       


<210>  10
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  10

Xaa Glu Val His His Xaa 
1               5       


<210>  11
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  11

Tyr Xaa Xaa His His Gln 
1               5       


<210>  12
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  12

Tyr Xaa Val His His Xaa 
1               5       


<210>  13
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  13

Tyr Glu Xaa His His Xaa 
1               5       


<210>  14
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  14

Xaa Xaa Xaa His His Gln 
1               5       


<210>  15
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  15

Xaa Xaa Val His His Xaa 
1               5       


<210>  16
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  16

Xaa Glu Xaa His His Xaa 
1               5       


<210>  17
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  amidation, reduction or glycosylation

<400>  17

Tyr Xaa Xaa His His Xaa 
1               5       


<210>  18
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  18

Asp Ala Glu Phe Arg His Asp Ser Gly Xaa Glu Val His His Gln 
1               5                   10                  15  


<210>  19
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  19

Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Xaa Val His His Gln 
1               5                   10                  15  


<210>  20
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  20

Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Xaa His His Gln 
1               5                   10                  15  


<210>  21
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  21

Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val His His Xaa 
1               5                   10                  15  


<210>  22
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  22

Asp Ala Glu Phe Arg His Asp Ser Gly Xaa Xaa Val His His Gln 
1               5                   10                  15  


<210>  23
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  23

Asp Ala Glu Phe Arg His Asp Ser Gly Xaa Glu Xaa His His Gln 
1               5                   10                  15  


<210>  24
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  24

Asp Ala Glu Phe Arg His Asp Ser Gly Xaa Glu Val His His Xaa 
1               5                   10                  15  


<210>  25
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  25

Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Xaa Xaa His His Gln 
1               5                   10                  15  


<210>  26
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  26

Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Xaa Val His His Xaa 
1               5                   10                  15  


<210>  27
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  27

Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Xaa His His Xaa 
1               5                   10                  15  


<210>  28
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  28

Asp Ala Glu Phe Arg His Asp Ser Gly Xaa Xaa Xaa His His Gln 
1               5                   10                  15  


<210>  29
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<400>  29

Asp Ala Glu Phe Arg His Asp Ser Gly Xaa Xaa Val His His Xaa 
1               5                   10                  15  


<210>  30
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  30

Asp Ala Glu Phe Arg His Asp Ser Gly Xaa Glu Xaa His His Xaa 
1               5                   10                  15  


<210>  31
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  31

Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Xaa Xaa His His Xaa 
1               5                   10                  15  


<210>  32
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  32

Asp Ala Glu Phe Xaa His Asp Ser Gly Xaa Xaa Xaa His His Gln 
1               5                   10                  15  


<210>  33
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  33

Asp Ala Glu Phe Xaa His Asp Ser Gly Xaa Xaa Val His His Xaa 
1               5                   10                  15  


<210>  34
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  34

Asp Ala Glu Phe Xaa His Asp Ser Gly Xaa Glu Xaa His His Xaa 
1               5                   10                  15  


<210>  35
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  35

Asp Ala Glu Phe Xaa His Asp Ser Gly Tyr Xaa Xaa His His Xaa 
1               5                   10                  15  


<210>  36
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  36

Asp Ala Xaa Phe Xaa His Asp Ser Gly Xaa Xaa Xaa His His Gln 
1               5                   10                  15  


<210>  37
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  37

Asp Ala Xaa Phe Xaa His Asp Ser Gly Xaa Xaa Val His His Xaa 
1               5                   10                  15  


<210>  38
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  38

Asp Ala Xaa Phe Xaa His Asp Ser Gly Xaa Glu Xaa His His Xaa 
1               5                   10                  15  


<210>  39
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  39

Asp Ala Xaa Phe Xaa His Asp Ser Gly Tyr Xaa Xaa His His Xaa 
1               5                   10                  15  


<210>  40
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  40

Asp Xaa Xaa Phe Xaa His Asp Ser Gly Xaa Xaa Xaa His His Gln 
1               5                   10                  15  


<210>  41
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  41

Asp Xaa Xaa Phe Xaa His Asp Ser Gly Xaa Xaa Val His His Xaa 
1               5                   10                  15  


<210>  42
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  42

Asp Xaa Xaa Phe Xaa His Asp Ser Gly Xaa Glu Xaa His His Xaa 
1               5                   10                  15  


<210>  43
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  43

Asp Xaa Xaa Phe Xaa His Asp Ser Gly Tyr Xaa Xaa His His Xaa 
1               5                   10                  15  


<210>  44
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  44

Xaa Xaa Xaa Phe Xaa His Asp Ser Gly Xaa Xaa Xaa His His Gln 
1               5                   10                  15  


<210>  45
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  45

Xaa Xaa Xaa Phe Xaa His Asp Ser Gly Xaa Xaa Val His His Xaa 
1               5                   10                  15  


<210>  46
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  46

Xaa Xaa Xaa Phe Xaa His Asp Ser Gly Xaa Glu Xaa His His Xaa 
1               5                   10                  15  


<210>  47
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  47

Xaa Xaa Xaa Phe Xaa His Asp Ser Gly Tyr Xaa Xaa His His Xaa 
1               5                   10                  15  


<210>  48
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  48

Asp Ala Glu Phe Arg Xaa Asp Ser Gly Xaa Glu Val His His Gln 
1               5                   10                  15  


<210>  49
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  49

Asp Ala Glu Phe Arg Xaa Asp Ser Gly Xaa Xaa Val His His Gln 
1               5                   10                  15  


<210>  50
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  50

Asp Ala Glu Phe Arg Xaa Asp Ser Gly Xaa Glu Xaa His His Xaa 
1               5                   10                  15  


<210>  51
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  51

Asp Ala Glu Phe Arg Xaa Asp Ser Gly Tyr Xaa Xaa His His Xaa 
1               5                   10                  15  


<210>  52
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  52

Asp Ala Glu Phe Arg Xaa Xaa Ser Gly Xaa Glu Val His His Gln 
1               5                   10                  15  


<210>  53
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  53

Asp Ala Glu Phe Arg Xaa Xaa Ser Gly Xaa Xaa Val His His Gln 
1               5                   10                  15  


<210>  54
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  54

Asp Ala Glu Phe Arg Xaa Xaa Ser Gly Xaa Glu Xaa His His Xaa 
1               5                   10                  15  


<210>  55
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  55

Asp Ala Glu Phe Arg Xaa Xaa Ser Gly Tyr Xaa Xaa His His Xaa 
1               5                   10                  15  


<210>  56
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Lys, or Arg

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  56

Asp Ala Glu Phe Arg Xaa Xaa Xaa Gly Xaa Glu Val His His Gln 
1               5                   10                  15  


<210>  57
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Lys, or Arg

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  57

Asp Ala Glu Phe Arg Xaa Xaa Xaa Gly Xaa Xaa Val His His Gln 
1               5                   10                  15  


<210>  58
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Lys, or Arg

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Phe, Tyr, or Trp

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  58

Asp Ala Glu Phe Arg Xaa Xaa Xaa Gly Xaa Glu Xaa His His Xaa 
1               5                   10                  15  


<210>  59
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  His, Lys, or Arg

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  amidation, reduction or glycosylation

<400>  59

Asp Ala Glu Phe Arg Xaa Xaa Xaa Gly Tyr Xaa Xaa His His Xaa 
1               5                   10                  15  


<210>  60
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  amidation, reduction or glycosylation

<400>  60

Ala Glu Phe Arg Xaa Xaa Xaa Xaa Xaa Glu Val His His Gln 
1               5                   10                  


<210>  61
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Asp or Glu

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  amidation, reduction or glycosylation

<400>  61

Glu Phe Arg Xaa Xaa Xaa Xaa Xaa Xaa Val His His Gln 
1               5                   10              


<210>  62
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Phe, Tyr, or Trp

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  amidation, reduction or glycosylation

<400>  62

Phe Arg Xaa Xaa Xaa Xaa Xaa Glu Xaa His His Xaa 
1               5                   10          


<210>  63
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified beta-amyloid peptide analogue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  an acetyl, glycosylation, or -CO-(CH2)nCH3, n=1 to 10

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  His, Lys, or Arg

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Ala, Gly, or Ser

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Ala, Gly, or Ser

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Val, Leu, Ile, or Met

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  D-amino Acid and/or N-methylated and/or beta-substituted amino 
       acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  His, Asn, or Gln

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  amidation, reduction or glycosylation

<400>  63

Arg Xaa Xaa Xaa Xaa Tyr Xaa Xaa His His Xaa 
1               5                   10      


